Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center

American Journal of Infection Control

Volumn 37, Issue 9, 2009, Pages 723-728

  Filozov, Alina ^a   Visintainer, Paul ^a   Carbonaro, Carol ^a   Aguero Rosenfeld, Maria ^a   Wormser, Gary P ^a   Montecalvo, Marisa A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONFIDENCE INTERVAL; EPIDEMIC; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; PULSED FIELD GEL ELECTROPHORESIS; RISK; RISK FACTOR; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CASE-CONTROL STUDIES; CHILD; CLUSTER ANALYSIS; CROSS INFECTION; DISEASE OUTBREAKS; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 71349084426     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2009.02.006     Document Type: Article

References (35)

1. Jacoby G.A., and Munoz-Price L.S. The new β-lactamases. N Engl J Med 352 (2005) 380-391
2. Knothe H., Shah P., Kremery V., Antal M., and Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole, and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcenscens. Infection 11 (1983) 315-317
3. Paterson D.L., Ko W.-C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 140 (2004) 26-32
4. Winokur P.L., Canton R., Casellas J.M., and Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clin Infect Dis 32 Suppl 2 (2001) S94-S103
5. Owens Jr. R.C., and Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis 42 Suppl 4 (2006) S173-S181
6. Rahal J.J., Urban C., Horn D., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280 (1998) 1233-1237
7. Bratu S., Landman D., Haag R., et al. Rapid spread of carbapenem resistance in New York City: a threat to our antibiotic armamentarium. Arch Intern Med 165 (2005) 1430-1435
8. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-828
9. Clinical and Laboratory Standards Institute/NCCLS. 2005. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. M100-S15, Vol.25 No. 1. Clinical and Laboratory Standards Institute, Wayne, Pa.
10. Tenover F.C., Arbeit R.D., Mickelsen P.A., et al. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
11. Brun-Buisson C., Legrand P., Philippon A., Montravers F., Ansquer M., and Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 2 8554 (1987) 302-306
12. De Champs C., Rouby D., Guelon D., et al. A case-control study of an outbreak of infections caused by Klebsiella pnumoniae strains producing CTX-1 (TEM-3) β-lactamase. J Hosp Infect 18 (1991) 5-13
13. Hobson R.P., MacKenzie F.M., and Gould I.M. An outbreak of multiple-resistant Klebsiella pnumoniae in the Grampian region of Scotland. J Hosp Infect 33 (1996) 249-262
14. Lucet J.-C., Chevret S., Decre D., et al. Outbreak of multiple-resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 22 (1996) 430-436
15. Peňa C., Pujol M., Ricart A., et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 35 (1997) 9-16
16. Meyer K.S., Urban C., Eagan J.A., Berger B.J., and Rahal J.J. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119 (1993) 353-358
17. D'Agata E.M., Venkataraman L., DeGirolami P., Weigel L., Samore M., and Tenover F. The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum β-lactamase in a tertiary care hospital. J Infect 36 (1998) 279-285
18. Bisson G., Fishman N.O., Patel J.B., Edelstein P.H., and Lautenbach E. Extended-spectrum β-lactamase-producing Escherichia Coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidimiol 23 (2002) 254-260
19. Kim Y.-K., Pai H., Lee H.-J., et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia Coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antmicrob Agents Chemother 46 (2002) 1481-1491
20. Piroth L., Aube H., Doise J.-M., and Vicent-Martin M. Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: are β-lactamase inhibitors of therapeutic value?. Clin Infect Dis 27 (1998) 76-80
21. Kang C.I., Kim S.H., Kim D.M., et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 25 (2004) 860-867
22. Peňa C., Pujol M., Ardanuy C., et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 42 (1998) 53-58
23. Schiappa D.A., Hayden M.K., Matushek M.G., et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 174 (1996) 529-536
24. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., and Fishman N.O. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32 (2001) 1162-1171
25. Rice L.B., Willey S.H., Papanicolaou G.A., et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother 34 (1990) 2193-2199
26. Naumovski L., Quinn J.P., Miyashiro D., et al. Outbreak of ceftazidime resistance dueto novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 36 (1992) 1991-1996
27. Quale J.M., Landman D., Bradford P.A., et al. Molecular epidemiology of a citywide outbreak of extended spectrum β-lactamase producing Klebsiella pneumoniae infection. Clin Infect Dis 35 (2002) 834-841
28. Asensio A., Oliver A., Gonzalez-Diego P., et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 30 (2000) 55-60
29. Lee S.O., Lee E.S., Park S.Y., Kim S.Y., Seo Y.H., and Cho Y.K. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 25 (2004) 832-837
30. Lin M.F., Huang M.L., and Lai S.H. Risk factors in the acquisition of extended-spectrum β-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 53 (2003) 39-45
31. Rice L.B., Eckstein E.C., Devente J., and Shlaes D.M. Ceftazidime-resistant Klebsiella pneumoniae at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 23 (1996) 118-124
32. Lipworth A.D., Hyle E.P., Fishman N.O., et al. Limiting the emergence of extended-spectrum β-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol 27 (2006) 279-286
33. Wiener J., Quinn J.P., Bradford P.A., et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281 (1999) 517-523
34. Paterson D.L., Ko W.-C., Von Gottberg A., et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin Infect Dis 39 (2003) 31-37
35. Lucet J.-C., Decre D., Fichelle A., et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis 29 (1999) 1411-1418